Tremella fuciformis polysaccharides ameliorated ulcerative colitis via inhibiting inflammation and enhancing intestinal epithelial barrier function

Hongyu Xiao,Hailun Li,Yifan Wen,Dongxu Jiang,Shumin Zhu,Xueling He,Qingping Xiong,Jie Gao,Shaozhen Hou,Song Huang,Lian He,Jian Liang
DOI: https://doi.org/10.1016/j.ijbiomac.2021.03.083
IF: 8.2
2021-06-01
International Journal of Biological Macromolecules
Abstract:<p>The purpose of this paper was to explore the therapeutic effect and underlying mechanism of <em>Tremella fuciformis</em> polysaccharides (TFP) on ulcerative colitis (UC) based on dextran sodium sulfate (DSS)-induced mice UC model and lipopolysaccharide (LPS)-stimulated Caco-2 cells model. The results firstly indicated that TFP can significantly alleviate the symptoms and signs of the DSS-induced mice UC model, which manifests as improvement of body weight loss, increase of colon length, decrease of colon thickness and reduction of intestinal permeability. Then, results from histopathological and electron microscope analysis further implied that TFP could dramatically reduce inflammatory cells infiltration and restore intestinal epithelial barrier integrity. In addition, the experiments of LPS-stimulated Caco-2 cells model <em>in vitro</em> also further confirmed that TFP could markedly inhibit the expressions of pro-inflammatory cytokines and increase related genes or proteins expressions of intestinal barrier and mucus barrier. Taken together, these data suggested that TFP has a significant therapeutic effect on DSS-induced UC model, and its mechanisms are closely linked to the inhibition of inflammation and the restoration of intestinal barrier and mucus barrier function. These beneficial effects may make TFP a promising drug to be used in alleviating UC.</p>
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?